Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I9AC
|
|||
| Drug Name |
SM04554
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alopecia [ICD-11: ED70; ICD-9: 704.09] | Phase 2/3 | [1] | |
| Company |
Samumed San Diego,CA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Wnt signaling pathway (Wnt pathway) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03742518) A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.